Evidence map›Paper›PMID 17329339›Full record

ArticleJournal of virology2007

Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.

C M Noviello, S L Kosakovsky Pond, M J Lewis, D D Richman, S K Pillai, O O Yang, S J Little, D M Smith, J C Guatelli

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

C M NovielloBiomedical Sciences Graduate Program, Department of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
S L Kosakovsky Pond
M J Lewis
D D Richman
S K Pillai
O O Yang
S J Little
D M Smith
J C Guatelli
Institute of Biomedical Science · GBUniversity of California, Los Angeles · USUniversity of California, San Diego · USVA San Diego Healthcare System · US

Funding

WOMEN'S HEALTH AGENDAU01AI038858 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI BENSON, CONSTANCE ANN · 1996 to 2008
$157.5M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel · 1994 to 2026
$78.4M
Primary Infection Resource Consortium (PIRC)R24AI106039 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET · 2013 to 2021
$23.1M
WOMEN'S HEALTH AGENDAU01AI027670 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 1988 to 2006
$13.7M
HIV-1 NEF AND VIRAL INFECTIVITYR01AI038201 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUATELLI, JOHN C. · 1996 to 2013
$4.1M
Immune Pressure on HIV-1 Nef by Cytotoxic T LymphocytesR01AI051970 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 2002 to 2011
$4.1M
Biomathematical analysis of viral dynamics/evolutionR01AI047745 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RICHMAN, DOUGLAS D · 2001 to 2011
$3.2M
ANTIVIRAL RESISTANCE IN AIDSR37AI029164 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI RICHMAN, DOUGLAS D · 1994 to 2004
$2.0M
Modeling HIV Escape from Neutralizing Antibody ResponesR01AI057167 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FROST, SIMON DAVID WILLIAM · 2004 to 2008
$1.2M
Compartmentalization of HIV within the genital tractK23AI055276 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2003 to 2007
$585k
Biomathematical Analysis of Viral Dynamics and EvolutionR56AI047745 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POND, SERGEI L KOSAKOVSKY · 2012 to 2012
$365k
HIV 1 NEF and InfectivityR21AI038201 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUATELLI, JOHN · 2003 to 2003
$331k
NIAID NIH HHS AI 047745NIAID NIH HHS AI 051970NIAID NIH HHS AI 27670NIAID NIH HHS AI 29164NIAID NIH HHS AI 36214NIAID NIH HHS AI 38201NIAID NIH HHS AI 38858NIAID NIH HHS AI 57167NIAID NIH HHS K23 AI 055276NIAID NIH HHS K23 AI055276NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI038201NIAID NIH HHS R01 AI047745NIAID NIH HHS R01 AI051970NIAID NIH HHS R01 AI057167NIAID NIH HHS R21 AI038201NIAID NIH HHS R21 AI047745NIAID NIH HHS R24 AI106039NIAID NIH HHS R37 AI029164NIAID NIH HHS R56 AI047745NIAID NIH HHS U01 AI027670NIAID NIH HHS U01 AI038858
6 · The paper itself

Abstract

Viruses encounter changing selective pressures during transmission between hosts, including host-specific immune responses and potentially varying functional demands on specific proteins. The human immunodeficiency virus type 1 Nef protein performs several functions potentially important for successful infection, including immune escape via down-regulation of class I major histocompatibility complex (MHC-I) and direct enhancement of viral infectivity and replication. Nef is also a major target of the host cytotoxic T-lymphocyte (CTL) response. To examine the impact of changing selective pressures on Nef functions following sexual transmission, we analyzed genetic and functional changes in nef clones from six transmission events. Phylogenetic analyses indicated that the diversity of nef was similar in both sources and acutely infected recipients, the patterns of selection across transmission were variable, and regions of Nef associated with distinct functions evolved similarly in sources and recipients. These results weighed against the selection of specific Nef functions by transmission or during acute infection. Measurement of Nef function provided no evidence that the down-regulation of either CD4 or MHC-I was optimized by transmission or during acute infection, although rare nef clones from sources that were impaired in these activities were not detected in recipients. Nef-specific CTL activity was detected as early as 3 weeks after infection and appeared to be an evolutionary force driving the diversification of nef. Despite the change in selective pressure between the source and recipient immune systems and concomitant genetic diversity, the majority of Nef proteins maintained robust abilities to down-regulate MHC-I and CD4. These data suggest that both functions are important for the successful establishment of infection in a new host.

Indexed as

Evolution, MolecularGene Expression Regulation, ViralGenetic VariationSelection, GeneticAmino Acid SequenceBase SequenceBlotting, WesternCD4 AntigensFlow CytometryGene Products, nefGenes, MHC Class IHIV-1HIV InfectionsHumansLikelihood FunctionsModels, GeneticCD4 AntigensGene Products, nefnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1

Identifiers

PMID17329339
PMCPMC1900175
OpenAlexW2116450549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.